Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries NeoGenomics, Inc. - Common Stock (NQ: NEO ) 17.28 +0.13 (+0.76%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 494,024 Open 16.95 Bid (Size) 16.89 (5) Ask (Size) 17.70 (5) Prev. Close 17.15 Today's Range 16.70 - 17.37 52wk Range 12.77 - 20.80 Shares Outstanding 122,816,314 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma December 11, 2024 From NeoGenomics, Inc. Via Business Wire Evaluating NeoGenomics: Insights From 4 Financial Analysts December 10, 2024 Via Benzinga Performance YTD +8.34% +8.34% 1 Month +0.58% +0.58% 3 Month +18.03% +18.03% 6 Month +29.54% +29.54% 1 Year -15.71% -15.71% More News Read More NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting December 09, 2024 From NeoGenomics, Inc. Via Business Wire Expert Ratings For NeoGenomics September 24, 2024 Via Benzinga NEO Stock Earnings: NeoGenomics Beats Revenue for Q2 2024 July 29, 2024 Via InvestorPlace NeoGenomics Earnings Analysis: Q1 Recap May 10, 2024 Via Benzinga Where NeoGenomics Stands With Analysts April 30, 2024 Via Benzinga NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment November 19, 2024 From NeoGenomics, Inc. Via Business Wire Felicia Williams Joins NeoGenomics Board of Directors November 14, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference November 08, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics Reports Third Quarter 2024 Results November 05, 2024 From NeoGenomics, Inc. Via Business Wire Earnings Scheduled For November 14, 2024 November 14, 2024 Via Benzinga NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test October 22, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 October 15, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia October 08, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation September 23, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment September 11, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 29, 2024 From NeoGenomics, Inc. Via Business Wire Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio? August 04, 2024 Via Benzinga Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 30, 2024 Via Benzinga PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday July 30, 2024 Via Benzinga NeoGenomics Reports Second Quarter 2024 Results July 29, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024 July 09, 2024 From NeoGenomics, Inc. Via Business Wire Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month June 13, 2024 From NeoGenomics, Inc. Via Business Wire NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management May 28, 2024 From NeoGenomics, Inc. Via Business Wire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
